CORT PEER ANALYSIS

Corcept Therapeutics Incorporated — metric-by-metric comparison with peers and the industry median

CORTCorcept Therapeutics Incorporated

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CORTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CORT	CSL	TLX	MSB	Ind. Median
P/E	199.72	30.02●	—	—	17.81
P/B	15.00	2.24●	6.56	—	3.49
EV/EBITDA	652.64	10.37●	123.31	—	14.92
P/S	12.44	2.67●	3.34	31.91	10.89

Financial Health
Metric	CORT	CSL	TLX	MSB	Ind. Median
Current Ratio	2.86●	2.57	1.43	—	5.90
Debt/Equity	1.5%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-23.21●	2.22	13.13	—	1.15

Profitability
Metric	CORT	CSL	TLX	MSB	Ind. Median
Net Margin	6.2%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	7.3%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	5.8%●	3.8%	-0.7%	-8.6%	-35.8%
EBITDA Margin	1.8%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	CORT	CSL	TLX	MSB	Ind. Median
Rev. Growth	12.2%	4.8%	56.3%	410.4%●	5.1%
NI Growth	-64.0%	-39.4%●	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	CORT	PTGX	APGE	IBRX	NUVL	HALO	Ind. Median
P/E	199.72	—	—	—	—	28.45●	17.81
P/B	15.00	14.14	7.41	-10.52●	8.29	45.19	3.49
EV/EBITDA	652.64	—	—	—	—	18.84●	14.92
P/S	12.44	125.16	—	64.90	—	6.58●	10.89

Financial Health
Metric	CORT	PTGX	APGE	IBRX	NUVL	HALO	Ind. Median
Current Ratio	2.86	17.76	32.59●	6.67	16.14	2.76	5.90
Debt/Equity	1.5%	1.5%	0.6%	-129.3%●	—	976.5%	10.9%
NetDebt/EBITDA	-23.21●	4.72	3.86	-1.02	—	2.93	1.15

Profitability
Metric	CORT	PTGX	APGE	IBRX	NUVL	HALO	Ind. Median
Net Margin	6.2%	-154.9%	—	-606.2%	—	23.1%●	-125.7%
ROE	7.3%	-17.1%	-28.5%	—	-41.2%	99.4%●	-47.5%
ROA	5.8%	-15.9%	-27.4%	-179.8%	-36.9%	14.3%●	-35.8%
EBITDA Margin	1.8%	-153.8%	—	-515.2%	—	41.4%●	-105.8%

Growth + Dividend
Metric	CORT	PTGX	APGE	IBRX	NUVL	HALO	Ind. Median
Rev. Growth	12.2%	-64.4%	-100.0%	351.5%●	—	39.1%	5.1%
NI Growth	-64.0%	—	—	—	—	-28.1%●	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CORT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.